C. Lund

632 total citations
21 papers, 395 citations indexed

About

C. Lund is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, C. Lund has authored 21 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in C. Lund's work include Lung Cancer Diagnosis and Treatment (5 papers), Head and Neck Cancer Studies (5 papers) and Advanced Radiotherapy Techniques (5 papers). C. Lund is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Head and Neck Cancer Studies (5 papers) and Advanced Radiotherapy Techniques (5 papers). C. Lund collaborates with scholars based in Canada, Denmark and United States. C. Lund's co-authors include A. P. Andersen, Karsten Juhl Jørgensen, O. Elbrønd, M. Hjelm-Hansen, Devin Schellenberg, Robert Olson, K. Bertelsen, Mitchell Liu, Jeffrey Cao and Hannah Carolan and has published in prestigious journals such as Journal of Clinical Oncology, Genetics and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

C. Lund

21 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Lund Canada 12 160 137 115 111 86 21 395
K. Matsuura Japan 12 92 0.6× 107 0.8× 121 1.1× 246 2.2× 116 1.3× 37 483
Helena Sjödin Sweden 7 210 1.3× 185 1.4× 92 0.8× 109 1.0× 40 0.5× 13 392
S. Guihard France 10 125 0.8× 116 0.8× 70 0.6× 100 0.9× 41 0.5× 47 342
Katrin Håkansson Denmark 11 195 1.2× 136 1.0× 95 0.8× 151 1.4× 144 1.7× 23 403
Zeming Mo China 7 143 0.9× 164 1.2× 85 0.7× 113 1.0× 46 0.5× 11 369
Gregory Vlacich United States 10 78 0.5× 89 0.6× 133 1.2× 152 1.4× 39 0.5× 23 324
Oyeon Cho South Korea 12 42 0.3× 202 1.5× 107 0.9× 96 0.9× 53 0.6× 28 378
Valentina Vanoni Italy 12 73 0.5× 98 0.7× 102 0.9× 97 0.9× 100 1.2× 21 332
Liliane Demange France 9 49 0.3× 95 0.7× 61 0.5× 91 0.8× 44 0.5× 22 356
Beata Biesaga Poland 12 48 0.3× 127 0.9× 59 0.5× 114 1.0× 108 1.3× 43 392

Countries citing papers authored by C. Lund

Since Specialization
Citations

This map shows the geographic impact of C. Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lund more than expected).

Fields of papers citing papers by C. Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lund. The network helps show where C. Lund may publish in the future.

Co-authorship network of co-authors of C. Lund

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lund. A scholar is included among the top collaborators of C. Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lund. C. Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lefresne, Shilo, M. J. Brown, Susan Ellard, et al.. (2023). A perspective on in person scientific meetings. Radiotherapy and Oncology. 184. 109691–109691. 1 indexed citations
2.
Baker, Sarah, Benjamin Mou, C. Lund, et al.. (2022). Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial. International Journal of Radiation Oncology*Biology*Physics. 114(4). 617–626. 21 indexed citations
4.
Dosani, Maryam, Runlin Yang, Don Wilson, et al.. (2019). Metabolic Tumour Volume Is Prognostic in Patients with Non-Small-Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy. Current Oncology. 26(1). 57–63. 22 indexed citations
5.
Olson, Robert, Mitchell Liu, Alanah Bergman, et al.. (2018). Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5. BMC Cancer. 18(1). 954–954. 10 indexed citations
6.
Lo, Andrea, Mitchell Liu, Elisa Chan, et al.. (2014). The Impact of Peer Review of Volume Delineation in Stereotactic Body Radiation Therapy Planning for Primary Lung Cancer: A Multicenter Quality Assurance Study. Journal of Thoracic Oncology. 9(4). 527–533. 50 indexed citations
7.
Lund, C., Jeffrey Cao, Mitchell Liu, et al.. (2013). The Distribution and Patterns of Practice of Stereotactic Ablative Body Radiotherapy in Canada. Journal of medical imaging and radiation sciences. 45(1). 8–15. 10 indexed citations
8.
Lund, C., et al.. (2011). The Current Patterns of Practice for Stereotactic Body Radiotherapy in Canada. International Journal of Radiation Oncology*Biology*Physics. 81(2). S559–S559. 1 indexed citations
9.
Hansen, Jannik, Lars Holst Hansen, Kirsten Christoffersen, et al.. (2011). Zackenberg Basic: The BioBasis programme. Research at the University of Copenhagen (University of Copenhagen). 43–66. 5 indexed citations
11.
Jaswal, Jagdip S., C. Lund, Wendy Keung, et al.. (2010). Isoproterenol stimulates 5′-AMP-activated protein kinase and fatty acid oxidation in neonatal hearts. American Journal of Physiology-Heart and Circulatory Physiology. 299(4). H1135–H1145. 14 indexed citations
12.
Simmons, Michael J, et al.. (1996). Repression of Hybrid Dysgenesis in Drosophila melanogaster by Heat-Shock-Inducible Sense and Antisense P-Element Constructs. Genetics. 144(4). 1529–1544. 26 indexed citations
13.
Jørgensen, Karsten Juhl, et al.. (1982). Carcinoma in a calcified pleomorphic adenoma of the submandibular gland. The Journal of Laryngology & Otology. 96(4). 373–376. 3 indexed citations
14.
Lund, C., Karsten Juhl Jørgensen, M. Hjelm-Hansen, & A. P. Andersen. (1979). Laryngeal Carcinoma: III. Treatment results in relation to microscopic score. PubMed. 18(6). 497–508. 16 indexed citations
15.
Hjelm-Hansen, M., Karsten Juhl Jørgensen, A. P. Andersen, & C. Lund. (1979). Laryngeal Carcinoma: II. Analysis of treatment results using the Ellis model. PubMed. 18(5). 385–407. 22 indexed citations
16.
Jørgensen, Karsten Juhl, M. Hjelm-Hansen, A. P. Andersen, & C. Lund. (1979). Laryngeal Carcinoma: I. Treatment results. PubMed. 18(4). 282–294. 13 indexed citations
17.
Andersen, A. P., K. Bertelsen, O. Elbrønd, C. Gadeberg, & C. Lund. (1977). Malignant Tumours of the Oropharynx. Acta Radiologica Therapy Physics Biology. 16(1). 63–72. 4 indexed citations
18.
Lund, C., H. Søgaard, Karsten Juhl Jørgensen, & M. Hjelm-Hansen. (1976). Epidermoid Carcinoma of the Larynx: VI. Histologic Grading in the Clinical Evaluation. Acta Radiologica Therapy Physics Biology. 15(4). 293–304. 11 indexed citations
19.
Bertelsen, K., A. P. Andersen, O. Elbrønd, & C. Lund. (1975). Malignant Tumours of the Nasopharynx. Acta Radiologica Therapy Physics Biology. 14(2). 177–186. 33 indexed citations
20.
Lund, C., et al.. (1975). Epidermoid Carcinoma of the Tongue Histologic Grading in the Clinical Evaluation. Acta Radiologica Therapy Physics Biology. 14(6). 513–521. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026